Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Horizon Therapeutics, a late-stage biopharmaceutical company, has appointed Robert De Vaere as its new executive vice president and CFO.
Subscribe to our email newsletter
Mr De Vaere’s most recent position was as senior vice president, finance and administration and CFO of IDM Pharma, a biopharmaceutical company focused on the development of innovative products that activate the immune system to treat cancer.
Additionally, Mr De Vaere served as vice president, finance and administration and CFO of IDM Pharma from August 2005 to March 2006, and was vice president and CFO of Epimmune from May 2000 until the business combination with IDM Pharma in August 2005.
Mr De Vaere has also served as CFO of Nexa Orthopedics, which was acquired by Tornier, and vice president of finance and administration and CFO of Vista Medical Technologies, a medical device company.
Timothy Walbert, president and CEO of Horizon Therapeutics, said: “Bob is an experienced executive who brings more than 28 years of financial management experience to Horizon, including the last decade in healthcare with both public and private companies. During his career, Bob has been instrumental in numerous M&A transactions as well as an IPO and will be an important part of Horizon’s future growth.”